LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
10.99
+0.67 (6.49%)
May 14, 2026, 1:26 PM EDT - Market open
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $103.23 million as of May 14, 2026. Its market cap has increased by 781.39% in one year.
Market Cap
103.23M
Enterprise Value
29.95M
1-Year Change
781.39%
Ranking
Category
Stock Price
$10.99
Market Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $103.23M, a decrease of -80.42%. That is a compound annual growth rate of -25.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 96.94M | 224.70% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| enGene Therapeutics | 103.16M |
| Aldeyra Therapeutics | 102.55M |
| Oncolytics Biotech | 101.15M |
| Q32 Bio | 100.72M |
| Vivani Medical | 100.03M |
| Seer, Inc. | 99.86M |
| NRx Pharmaceuticals | 97.45M |
| Anixa Biosciences | 97.23M |